Wynnefield Partners Small Cap Value LP's Form 4 filing
Lifecore Biomedical, Inc. DE (LFCR) · filed Jan 18, 2023
- Accession no.
- 0001104659-23-004663
- Filed
- Jan 18, 2023, 5:23 PM ET
- Trade date
- Nov 25, 2022
- Filing delay
- 54 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.00M. It was filed 54 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wynnefield Partners Small Cap Value LPCIK 0000899083 | 10% Owner |
| Obus NelsonCIK 0001017043 | 10% Owner |
| Wynnefield Small Cap Value Offshore Fund LtdCIK 0001030806 | 10% Owner |
| Wynnefield Capital Management LLCCIK 0001056835 | 10% Owner |
| Wynnefield Partners Small Cap Value LP ICIK 0001251565 | 10% Owner |
| Wynnefield Capital IncCIK 0001251567 | 10% Owner |
| Landes JoshuaCIK 0001251568 | 10% Owner |
| Wynnefield Capital, Inc. Profit Sharing PlanCIK 0001289453 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2022 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +345,260 | $7.97 | +$2,751,722.2 | 1,972,853 | Direct | |
| Nov 25, 2022 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +282,486 | $7.97 | +$2,251,413.42 | 2,438,180 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.